Conservative care has changed dramatically in the last decade. The evidence is clearer about what works, what doesn't, and what's just expensive marketing. This guide separates the science from the noise.
India has the world's second-largest population of patients with knee arthritis. The orthopaedic industry is incentivised to recommend surgery. Patients are bombarded with claims about glucosamine, copper bracelets, magnetic therapy, "cartilage regeneration," stem cells, and other expensive interventions.
The honest answer: 60–70% of patients with Grade 1–3 knee arthritis can avoid or significantly delay surgery with the right combination of evidence-based interventions. The other 30–40% genuinely need replacement.
This guide tells you which is which.
For a typical patient with Grade 2–3 knee OA without mechanical symptoms (no locking, no giving way), here's the evidence-based sequence:
Months 0–3:
Months 3–6 (if not improving enough):
Months 6–12 (if still not adequately controlled):
If mechanical symptoms develop (locking, giving way), MRI and surgical consultation moves up the timeline.
At Gini, we built the Save the Knee Programme to deliver this sequence as an integrated package. Patients work with:
The honest goal: delay or avoid replacement in patients who don't yet need it. We'll tell you when you do.
Conservative care has limits. Surgery is genuinely indicated when:
More on when to consider knee replacement →
If you genuinely meet these criteria, modern knee replacement is excellent — 95% of patients are satisfied at 5 years. Robotic / navigated surgery further improves alignment precision.
Have a question about your case? Book an appointment or call our 24/7 emergency line.